Fibroblast growth factor 21 potently reduces atherosclerosis and NASH development. (August 2022)
- Record Type:
- Journal Article
- Title:
- Fibroblast growth factor 21 potently reduces atherosclerosis and NASH development. (August 2022)
- Main Title:
- Fibroblast growth factor 21 potently reduces atherosclerosis and NASH development
- Authors:
- Liu, C.
Schönke, M.
Spoorenberg, B.
Lambooij, J.
Hendrik, V.D.Z.
Zhou, E.
Dekker, N.
Andréasson, A.-C.
Park, A.
Uhrbom, M.
Ahlstedt, I.
Ikeda, Y.
Wallenius, K.
Peng, X.-R.
Guigas, B.
Boon, M.
Wang, Y.
Rensen, P. - Abstract:
- Is Part Of:
- Atherosclerosis. Volume 355(2022)
- Journal:
- Atherosclerosis
- Issue:
- Volume 355(2022)
- Issue Display:
- Volume 355, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 355
- Issue:
- 2022
- Issue Sort Value:
- 2022-0355-2022-0000
- Page Start:
- 43
- Page End:
- Publication Date:
- 2022-08
- Subjects:
- Arteriosclerosis -- Periodicals
Electronic journals
616.136 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.atherosclerosis.2022.06.210 ↗
- Languages:
- English
- ISSNs:
- 0021-9150
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23286.xml